Waldenström Macroglobulinemia
📧 Sign up to get email alerts when something new happens for Waldenström Macroglobulinemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Zanubrutinib in Patients With Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma and Follicular Lymphoma
This clinical trial update reports that recruitment is ongoing for a study evaluating zanubrutinib in patients with Waldenström's macroglobu…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Ibrutinib Followed by BR (Bendamustine and Rituximab) as a Time-Limited Therapy for Waldenström Macroglobulinemia [Phase 1]
Clinical trial update: A Phase 1 study is evaluating time-limited therapy with ibrutinib followed by bendamustine and rituximab in Waldenstr…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Prognostic Value of Circulating Tumoral DNA After the First 6 Months of Treatment in Patients With Waldenström Macroglobulinemia [NA]
This clinical trial investigates whether circulating tumor DNA after six months of treatment can predict outcomes in patients with Waldenstr…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: This Study Aims to Clarify the Prevalence and Characteristics of Neuropathy, Along With Associated Paraclinical Findings in Patients With Waldenström's Macroglobulinemia (WM) in a Cohort of WM Patients to Optimize the Diagnostic Process
This clinical trial is investigating how common neuropathy is in patients with Waldenström macroglobulinemia and aims to describe related pa…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas [Phase 1]
Phase 1 clinical trial evaluating autologous CD22-directed CAR-T cells in patients with recurrent or refractory B-cell lymphomas, including …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Combating Cancer-Related Fatigue: A Personalized Supportive Care Program [NA]
This clinical trial update reports a UNC Lineberger Comprehensive Cancer Center study recruiting participants for a personalized supportive …
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing
An ongoing clinical trial update describes using phased variant analysis with next-generation sequencing to enable early assessment of lymph…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Clinical Study of the Hyperviscosity Syndrome in Waldenström Macroglobulinemia [NA]
This is an ongoing clinical study evaluating hyperviscosity syndrome in patients with Waldenström macroglobulinemia; the study is currently …
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: Pirtobrutinib and Venetoclax in Waldenström Macroglobulinemia [Phase 2]
Phase 2 study evaluating pirtobrutinib in combination with venetoclax for Waldenström macroglobulinemia is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: Zanubrutinib Combined With BR in the First-line Treatment of Waldenström's Macroglobulinemia [NA]
This clinical trial is evaluating first-line zanubrutinib in combination with bendamustine and rituximab for Waldenström's macroglobulinemia…
-
CLINICAL_TRIALS research · 2025-04-20Clinical Trial Update: Rifaximin in Patients With Monoclonal Gammopathy [Phase 1]
Phase 1 clinical trial evaluating rifaximin in patients with monoclonal gammopathy; status is active but not recruiting.
-
CLINICAL_TRIALS research · 2024-08-28Clinical Trial Update: Zanubrutinib Plus BR in Newly Diagnosed Symptomatic WM [Phase 2]
A Phase 2 study evaluating zanubrutinib plus bendamustine-rituximab for newly diagnosed symptomatic Waldenström macroglobulinemia, currently…
-
CLINICAL_TRIALS research · 2024-05-10Clinical Trial Update: Rituximab and Ibrutinib (RI) Versus Dexamethasone, Rituximab and Cyclophosphamide (DRC) as Initial Therapy for Waldenström's Macroglobulinaemia [Phase 2, Phase 3]
A Phase 2/Phase 3 randomized trial at University College London compares Rituxan (rituximab) plus Ibrutinib versus Dexamethasone, Rituxan, a…
-
CLINICAL_TRIALS research · 2017-11-07Clinical Trial Update: Study of VTD in Waldenstrom's Macroglobulinemia [Phase 2]
Phase 2 clinical trial investigating the VTD regimen (bortezomib, thalidomide, dexamethasone) for Waldenström's macroglobulinemia and lympho…
-
CLINICAL_TRIALS research · 2017-07-19Clinical Trial Update: Study of Safety,Efficacy and Pharmacokinetics of CT-1530 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia [Phase 1, Phase 2]
Clinical trial update describing a Phase 1/Phase 2 study of CT-1530 in relapsed or refractory B-cell non-Hodgkin lymphoma, chronic lymphocyt…
-
CLINICAL_TRIALS research · 2013-12-18Clinical Trial Update: Beta Alethine in Treating Patients With Waldenstrom's Macroglobulinemia [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Beta Alethine for Waldenström's macroglobulinemia is reported. Sponsor is LifeTime Pharmaceuticals and…
-
CLINICAL_TRIALS research · 2013-12-18Clinical Trial Update: Collecting Stem Cells in Patients With Waldenstrom's Macroglobulinemia
This clinical trial update describes collecting stem cells from patients with Waldenström macroglobulinemia. The current trial status is lis…